H5N1 avian influenza (bird flu) found in birds in Victoria

August 5, 2026

Avian influenza (bird flu) is a disease caused by different strains of the bird flu virus that can spread between wild and domestic birds. Bird flu continues to pose a low risk to human health, with no evidence of sustained human-to-human transmission.

However, following recent detection of H5N1 bird flu in birds in Victoria, GPs should remain aware of the condition, particularly in patients with relevant exposure to infected birds or contaminated environments.

While rare, people can catch it through close contact with sick birds or animals, their environments, or from a person infected with bird flu.

There is no specific vaccine available for bird flu. The seasonal flu (human influenza) vaccine can reduce the risk of being infected of both influenza and bird flu strains at the same time.

Influenza vaccination is strongly recommended for poultry workers, people who work with birds and other animals, and people travelling overseas to countries that have bird flu.

Healthcare professionals should consider bird flu in patients who present with influenza-like illness AND who have had contact with sick or dead birds or animals in the 10 days before the onset of symptoms. Medical practitioners and pathology services must notify any suspected or confirmed cases immediately to the department of health by calling 1300 651 160 (24/7) and connecting to the relevant Local Public Health Unit

Learn more

Latest news

August 19, 2026
Every patient consultation provides an opportunity to review a patient’s immunisation history and vaccination status, while talking through any questions or concerns they may have about vaccination.
August 17, 2026
The purpose of this activity is to ensure that patients with both a mental health and chronic disease diagnosis are identified and proactively offered guidance and support to register with MyMedicare, improving care coordination and access to relevant incentives and services.
August 12, 2026
Recent vaccine supply and distribution issues have caused temporary vaccine shortages of the Capvaxive ® (pneumococcal) vaccine.